2 recruiting, 1 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 2, Completed 1 |
| Phase 2 | 2 | Recruiting 2 |
Follow T1D: new trials by email Literature Review of T1D trials Research Report on T1D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus OPF-310 - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 1 / Phase 2 | Recruiting | Otsuka Pharmaceutical Factory, Inc. | 13 | 2025-06-10 | 2026-08-21 |
| CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) CNP-103, Placebo - Type 1 Diabetes Mellitus, T1D | Phase 1 / Phase 2 | Recruiting | COUR Pharmaceutical Development Company, Inc. | 72 | 2025-05-12 | 2026-09-11 |
| Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors SGLT-2 inhibitor - Diabetes, Type1diabetes | Phase 1 | Completed | McGill University | 24 | 2024-12-05 | 2026-09-25 |
Diabetes Mellitus (3) · Diabetes Mellitus, Type 1 (2) · Autoimmune Diseases (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Motor Activity (1)
Endocrine System Diseases (3) · Nutritional and Metabolic Diseases (3) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Autoimmune Diseases (1) · Behavior (1) · Immune System Diseases (1)
Sodium-Glucose Transporter 2 Inhibitors (1) · Therapeutics (1) · empagliflozin (1)
COUR Pharmaceutical Development Company, Inc. (1) · McGill University (1) · Otsuka Pharmaceutical Factory, Inc. (1)
United States (2) · Canada (1)
Michael Tsoukas, M.D. (1) · Paul Peloso, MD (1)